Arena Capital Advisors, LLC- CA - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 35 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$5,737
+473.7%
19,2510.0%0.00%
Q3 2022$1,000
-85.7%
19,251
-72.2%
0.00%
-100.0%
Q2 2022$7,000
-50.0%
69,2510.0%0.00%0.0%
Q1 2022$14,000
-76.7%
69,251
-31.0%
0.00%
-66.7%
Q4 2021$60,000
-3.2%
100,2990.0%0.01%
+20.0%
Q3 2021$62,000
+158.3%
100,299
+301.2%
0.01%
+150.0%
Q2 2021$24,00025,0000.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Athanor Capital, LP 39,251$380,0000.05%
Radcliffe Capital Management, L.P. 66,666$649,0000.02%
Arena Capital Advisors, LLC- CA 100,299$62,0000.01%
Exos Asset Management LLC 15,100$9,0000.01%
MARSHALL WACE, LLP 108,584$1,057,0000.00%
MMCAP International Inc. SPC 77,425$48,0000.00%
GABELLI & Co INVESTMENT ADVISERS, INC. 21,896$14,0000.00%
Atalaya Capital Management LP 13,333$8,0000.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 100,000$62,0000.00%
FIR TREE CAPITAL MANAGEMENT LP 49,997$29,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders